{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:52:18Z","timestamp":1649134338255},"reference-count":21,"publisher":"Akademiai Kiado Zrt.","issue":"18","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Orvosi Hetilap"],"published-print":{"date-parts":[[2012,5]]},"abstract":"<jats:p> Sodium-glucose co-transporters (SGLTs) have a key role in the re-absorption of glucose in the kidneys. Therefore, inhibition of SGLTs may provide a novel therapeutic strategy for diabetes mellitus. SGLT2 inhibitors enhance renal glucose excretion by inhibiting renal glucose re-absorption and reduce plasma glucose level, as well as they decrease the body weight. Their action is insulin independent and they improve insulin resistance in diabetes mellitus. Numerous SGLT2 inhibitors have been developed and evaluated in clinical trials. Phase III trials are needed to assess the safety of SGLT2 inhibitors. Results suggest that the beneficial effects of SGLT2 inhibition might be achieved without the development of significant side effects. Orv. Hetil., 2012, 153, 695\u2013701. <\/jats:p>","DOI":"10.1556\/oh.2012.29351","type":"journal-article","created":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T01:25:45Z","timestamp":1335835545000},"page":"695-701","source":"Crossref","is-referenced-by-count":0,"title":["New possibility in the oral glucose lowering treatment of type 2 diabetes mellitus: sodium-glucose co-transporter-2 inhibitors"],"prefix":"10.1556","volume":"153","author":[{"given":"G\u00e1bor","family":"Simonyi","sequence":"first","affiliation":[{"name":"Pest Megyei Fl\u00f3r Ferenc K\u00f3rh\u00e1z, Kardiometabolikus Centrum V. Belgy\u00f3gy\u00e1szat-Lipidol\u00f3giai Oszt\u00e1ly, Region\u00e1lis Zs\u00edranyagcsere-k\u00f6zpont \u00e9s Hypertonia Decentrum Kistarcsa Semmelweis t\u00e9r 3. 2143"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"425","reference":[{"key":"atypb1","first-page":"1","volume":"19","year":"2011","journal-title":"Diabetologia Hungarica"},{"key":"atypb2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1365-2796.2006.01746.x","volume":"261","year":"2007","journal-title":"J. Intern. Med."},{"key":"atypb3","first-page":"139","volume":"1","year":"2010","journal-title":"International Journal of Pharma Sciences and Research"},{"key":"atypb4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/nrd3180","volume":"9","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"key":"atypb5","first-page":"285","volume":"8","year":"2007","journal-title":"Curr. Opin. Investig. Drugs"},{"key":"atypb6","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1007\/s00439-002-0820-5","volume":"111","year":"2002","journal-title":"Hum. Genet."},{"key":"atypb7","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1097\/01.ASN.0000092790.89332.D2","volume":"14","year":"2003","journal-title":"J. Am. Soc. Nephrol."},{"key":"atypb8","first-page":"0040-LB","volume":"60","year":"2011","journal-title":"Diabetes"},{"key":"atypb9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/dmrr.532","volume":"21","year":"2005","journal-title":"Diabetes Metab. Res. Rev."},{"key":"atypb10","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1172\/JCI112981","volume":"79","year":"1987","journal-title":"J. Clin. Invest."},{"key":"atypb11","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1177\/0091270009352185","volume":"50","year":"2010","journal-title":"J. Clin. Pharmacol."},{"key":"atypb12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1124\/jpet.108.140210","volume":"327","year":"2008","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"atypb13","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.2337\/db07-1472","volume":"57","year":"2008","journal-title":"Diabetes"},{"key":"atypb14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/dc08-1863","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"atypb15","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/clpt.2008.251","volume":"85","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"atypb16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/clpt.2008.250","volume":"85","year":"2009","journal-title":"Clin. Pharmacol. Ther."},{"key":"atypb17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.2337\/dc08-1863","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"atypb18","first-page":"S76","volume":"52","year":"2009","journal-title":"Diabetologia"},{"key":"atypb19","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.2337\/dc09-0517","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"atypb23","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1476-5381.2011.01340.x","volume":"164","year":"2011","journal-title":"Br. J. Pharmacol."},{"key":"atypb26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1177\/1474651410377832","volume":"10","year":"2010","journal-title":"Br. J. Diabetes Vasc. Dis."}],"container-title":["Orvosi Hetilap"],"original-title":[],"language":"hu","link":[{"URL":"https:\/\/www.akademiai.com\/doi\/pdf\/10.1556\/OH.2012.29351","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T09:51:46Z","timestamp":1590141106000},"score":1,"resource":{"primary":{"URL":"https:\/\/akjournals.com\/doi\/10.1556\/oh.2012.29351"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":21,"journal-issue":{"issue":"18","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["10.1556\/OH.2012.29351"],"URL":"https:\/\/doi.org\/10.1556\/oh.2012.29351","relation":{},"ISSN":["0030-6002","1788-6120"],"issn-type":[{"value":"0030-6002","type":"print"},{"value":"1788-6120","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}